About us

Coriolis Pharma is a globally operating contract research organization (CRO) and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs, including cell and gene therapy products and vaccines. Founded in 2008, Coriolis is the expert for early and late-stage biopharmaceutical development of liquid and lyophilized drug products, including lyophilization process development and analytical method development under R&D and GMP.  Non-GMP manufacturing services for a wide range of products complete the service portfolio. We have supported the successful development of many drug products and our scientists are eager to apply their experience to your project.

Our mission

Our motivation is to enable the development of innovative drugs by performing outstanding biopharmaceutical research to improve the quality of life for humankind.

Our vision

We enable innovative therapies by revolutionizing formulation development.

We revolutionize the development process of biopharmaceutical drugs by integrating innovative digital formulation approaches from drug development to commercial products. We thereby enable future therapies to be made available to humankind efficiently and on time.

Our strategy

For us innovation is progress achieved by collaboration. We generate innovation by combining technologies, knowledge and experience. Formulating for us means: to find the best solution right from the start combined with speed and flexibility.